• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度糖尿病患病率:IDF 糖尿病地图集第 10 版综述。

Prevalence of Diabetes in India: A Review of IDF Diabetes Atlas 10th Edition.

机构信息

Department of Pharmacy Practice, ISF College of Pharmacy, Moga, India.

出版信息

Curr Diabetes Rev. 2024;20(1):e130423215752. doi: 10.2174/1573399819666230413094200.

DOI:10.2174/1573399819666230413094200
PMID:37069712
Abstract

Diabetes is a severe chronic disease that arises when insulin generation is insufficient, or the generated insulin cannot be used in the body, resulting a long-term metabolic disorder. Diabetes affects an estimated 537 million adults worldwide between the age of 20 to 79 (10.5% of all adults in this age range). By 2030, 643 million people will have diabetes globally, increasing to 783 million by 2045. According to the IDF 10th edition, the incidence of diabetes has been rising in South-East Asia (SEA) nations for at least 20 years, and current estimates have outperformed all previous forecasts. This review aims to provide updated estimates and future projections of diabetes prevalence at the national and global levels by using data from the 10th edition of the IDF Diabetes Atlas 2021. For this review, we studied more than 60 previously published related articles from various sources, such as PubMed and Google Scholar, and we extracted 35 studies out of 60. however, we used only 34 studies directly related to diabetes and its prevalence at the global, SEA, and Indian levels. This review article concludes that in 2021 more than 1 in 10 adults worldwide developed diabetes. The estimated prevalence of diabetes in adults (20 to 79 years) has more than tripled since the first edition in 2000, rising from an estimated 151 million (4.6% of the world's population at the time) to 537.5 million (10.5%) of the world's population today. The prevalence rate will be higher than 12.8% by 2045. In addition, this study indicates that the incidence of diabetes in the world, Southeast Asia, and India was 10.5%, 8.8%, and 9.6%, respectively, throughout 2021 and will rise to 12.5%, 11.5%, and 10.9%, respectively by 2045.

摘要

糖尿病是一种严重的慢性疾病,当胰岛素生成不足或生成的胰岛素无法在体内使用时就会发生,导致长期代谢紊乱。全球估计有 20 至 79 岁的 5.37 亿成年人患有糖尿病(该年龄段所有成年人的 10.5%)。到 2030 年,全球将有 6.43 亿人患有糖尿病,到 2045 年将增加到 7.83 亿。根据 IDF 第 10 版,东南亚(SEA)国家的糖尿病发病率至少在过去 20 年中一直在上升,目前的估计值超过了所有先前的预测。本综述旨在使用 2021 年国际糖尿病联盟(IDF)第 10 版糖尿病地图集的数据,提供国家和全球层面糖尿病患病率的最新估计和未来预测。为此,我们研究了来自 PubMed 和 Google Scholar 等各种来源的 60 多篇先前发表的相关文章,并从 60 篇文章中提取了 35 篇。然而,我们仅使用了 34 篇直接与全球、SEA 和印度的糖尿病及其患病率相关的研究。这篇综述文章得出结论,2021 年全球每 10 名成年人中就有 1 人以上患有糖尿病。自 2000 年第一版以来,成年人(20 至 79 岁)中糖尿病的估计患病率增加了两倍多,从当时估计的 1.51 亿(占世界人口的 4.6%)增加到 5.375 亿(占世界人口的 10.5%)。到 2045 年,这一比例将高于 12.8%。此外,本研究表明,2021 年全球、东南亚和印度的糖尿病发病率分别为 10.5%、8.8%和 9.6%,到 2045 年将分别上升至 12.5%、11.5%和 10.9%。

相似文献

1
Prevalence of Diabetes in India: A Review of IDF Diabetes Atlas 10th Edition.印度糖尿病患病率:IDF 糖尿病地图集第 10 版综述。
Curr Diabetes Rev. 2024;20(1):e130423215752. doi: 10.2174/1573399819666230413094200.
2
Impact of Type 2 Diabetes Mellitus with a Focus on Asian Indians Living in India and Abroad: A Systematic Review.2 型糖尿病的影响:重点关注在印度和海外生活的亚裔印度人:系统评价。
Endocr Metab Immune Disord Drug Targets. 2023;23(5):609-616. doi: 10.2174/1871530322666220827161236.
3
4
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.国际糖尿病联盟(IDF)糖尿病地图集:2021 年全球、区域和国家糖尿病患病率估算值以及 2045 年预测值。
Diabetes Res Clin Pract. 2022 Jan;183:109119. doi: 10.1016/j.diabres.2021.109119. Epub 2021 Dec 6.
5
IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.国际糖尿病联盟糖尿病地图集:2011 年和 2030 年全球糖尿病患病率估计。
Diabetes Res Clin Pract. 2011 Dec;94(3):311-21. doi: 10.1016/j.diabres.2011.10.029. Epub 2011 Nov 12.
6
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition.2019 年全球及各区域糖尿病患病率估算值及 2030 年和 2045 年预测值:国际糖尿病联盟糖尿病地图集(第 9 版)的结果。
Diabetes Res Clin Pract. 2019 Nov;157:107843. doi: 10.1016/j.diabres.2019.107843. Epub 2019 Sep 10.
7
IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021.国际糖尿病联盟糖尿病地图集:2021 年全球成年人未诊断糖尿病估计数。
Diabetes Res Clin Pract. 2022 Jan;183:109118. doi: 10.1016/j.diabres.2021.109118. Epub 2021 Dec 6.
8
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.国际糖尿病联盟(IDF)糖尿病地图集:2017 年全球糖尿病患病率估计数和 2045 年预测值。
Diabetes Res Clin Pract. 2018 Apr;138:271-281. doi: 10.1016/j.diabres.2018.02.023. Epub 2018 Feb 26.
9
Global estimates of the prevalence of hyperglycaemia in pregnancy.全球妊娠期高血糖症患病率的估计。
Diabetes Res Clin Pract. 2014 Feb;103(2):176-85. doi: 10.1016/j.diabres.2013.11.003. Epub 2013 Dec 1.
10
Diabetes and global ageing among 65-99-year-old adults: Findings from the International Diabetes Federation Diabetes Atlas, 9 edition.糖尿病与 65 岁及以上成年人的全球老龄化:国际糖尿病联合会糖尿病地图集,第 9 版的研究结果。
Diabetes Res Clin Pract. 2020 Apr;162:108078. doi: 10.1016/j.diabres.2020.108078. Epub 2020 Feb 14.

引用本文的文献

1
Preparation Methods of Hydrogel Microspheres and Recent Advances in Their Application for Treating Diabetic Wounds.水凝胶微球的制备方法及其在治疗糖尿病伤口中的应用新进展
Int J Nanomedicine. 2025 Aug 30;20:10645-10666. doi: 10.2147/IJN.S527650. eCollection 2025.
2
Impact of Climate Change on the Composition and Bioactivity of Essential Oils: In Vitro, , and ADME Analysis.气候变化对香精油成分和生物活性的影响:体外、体内及药物代谢动力学分析
Food Sci Nutr. 2025 Sep 1;13(9):e70845. doi: 10.1002/fsn3.70845. eCollection 2025 Sep.
3
Association between GLP-1 receptor agonists as a class and colorectal cancer risk: a meta-analysis of retrospective cohort studies.
GLP-1受体激动剂作为一类药物与结直肠癌风险之间的关联:一项回顾性队列研究的荟萃分析
BMC Gastroenterol. 2025 Aug 22;25(1):614. doi: 10.1186/s12876-025-04211-4.
4
The association between Dietary Obesity-Prevention Score (DOS) and type 2 diabetes (T2D): a case-control study.饮食性肥胖预防评分(DOS)与2型糖尿病(T2D)之间的关联:一项病例对照研究。
Front Nutr. 2025 Jul 30;12:1594626. doi: 10.3389/fnut.2025.1594626. eCollection 2025.
5
Prospective Assessment of Alzheimer's Disease-Like Hypometabolism Pattern in the Brain of Diabetics in Contrast to Non-diabetics on Positron Emission Tomography-Computed Tomography Images Using Fluorodeoxyglucose in India.在印度,使用氟脱氧葡萄糖通过正电子发射断层扫描-计算机断层扫描图像对糖尿病患者大脑中类似阿尔茨海默病的低代谢模式与非糖尿病患者进行前瞻性评估。
Cureus. 2025 Aug 9;17(8):e89682. doi: 10.7759/cureus.89682. eCollection 2025 Aug.
6
Efficacy and Safety of Femtosecond Laser-Assisted Cataract Surgery with the Catalys Platform in Patients with Type 2 Diabetes and Cataract: A Prospective Cohort Study.使用Catalys平台的飞秒激光辅助白内障手术治疗2型糖尿病合并白内障患者的疗效与安全性:一项前瞻性队列研究
Ophthalmol Ther. 2025 Sep;14(9):2301-2312. doi: 10.1007/s40123-025-01218-8. Epub 2025 Jul 29.
7
SGLT2 Inhibitors: From Structure-Effect Relationship to Pharmacological Response.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂:从构效关系到药理反应
Int J Mol Sci. 2025 Jul 19;26(14):6937. doi: 10.3390/ijms26146937.
8
The effectiveness and safety of nanocurcumin supplementation for diabetic peripheral neuropathy in patients with type 2 diabetes: a randomized double-blind clinical trial.纳米姜黄素补充剂对2型糖尿病患者糖尿病周围神经病变的有效性和安全性:一项随机双盲临床试验。
Nutr J. 2025 Jul 18;24(1):115. doi: 10.1186/s12937-025-01184-8.
9
SDF-1α loaded lipid liquid crystalline hydrogel accelerates diabetic wound healing in in vitro and in vivo models.负载基质细胞衍生因子-1α的脂质液晶水凝胶在体外和体内模型中均能加速糖尿病伤口愈合。
Sci Rep. 2025 Jul 18;15(1):26188. doi: 10.1038/s41598-025-10756-x.
10
Expediting multiple biological properties of main bioactive compounds of Mentha pulegium L.加速唇萼薄荷主要生物活性化合物的多种生物学特性
AMB Express. 2025 Jul 14;15(1):105. doi: 10.1186/s13568-025-01911-8.